Site maintenance Wednesday, November 13th, 2024. Please note that access to some content and account information will be unavailable on this date.
Skip to main content

Abstract

OBJECTIVE: Regular physical activity is anxiolytic for both healthy subjects and patients with panic disorder. However, the acute antipanic activity of exercise has not yet been studied systematically. METHOD: The effects of quiet rest or aerobic treadmill exercise (30 minutes at 70% of maximum oxygen consumption) on cholecystokinin tetrapeptide (CCK-4)-induced panic attacks were studied in a crossover design in 15 healthy subjects. The effects were measured with the Acute Panic Inventory. RESULTS: Panic attacks occurred in 12 subjects after rest but in only six subjects after exercise. In both conditions, CCK-4 administration was followed by a significant increase in Acute Panic Inventory scores; however, prior exercise resulted in significantly lower scores than quiet rest. CONCLUSIONS: Aerobic exercise has an acute antipanic activity in healthy subjects. If the authors’ results are confirmed in patients, the optimum intensity and duration of acute exercise for achieving antipanic effects will have to be characterized.
The anxiolytic effects of training in aerobic exercise have been described in numerous studies in healthy volunteers (1). In line with this, case reports (2) and two clinical studies have suggested that exercise training may be used therapeutically in patients with anxiety neurosis (3) and panic disorder (4). In addition, studies in healthy subjects and two case reports (5, 6) have suggested that an acute bout of exercise is anxiolytic as well. In contrast, exercise may induce acute panic attacks (4, 7) or increase subjective anxiety in patients with panic disorder more than in other people (8). To our knowledge, the potential acute antipanic activity of exercise has not been studied systematically.
Acute bouts of exercise have been shown to reduce symptoms induced by CO2 and caffeine (9, 10). However, CO2 and caffeine primarily induce somatic symptoms of anxiety in healthy subjects but rarely panic attacks. In contrast, cholecystokinin tetrapeptide (CCK-4) dose dependently and reliably induces panic attacks in healthy comparison subjects (11). Therefore, we studied the potential acute antipanic effects of aerobic exercise in healthy volunteers after CCK-4 administration and compared CCK-4-induced panic attacks with and without previous exercise.

Method

Fifteen healthy subjects (six women and nine men; mean age=26.4 years, SD=3.8) with no personal (12) or family history of a psychiatric disorder were recruited for the study. The subjects did not take any medication and had undergone a thorough medical examination to rule out other illnesses, drug intake, and lifestyles (sleep deprivation, changes in the sleep-wake cycle) that could interfere with the study. The protocol was approved by the local ethics committee for human experiments. After a complete description of the study to the subjects, written informed consent was obtained. The subjects were paid for their participation. Before the experiment, a treadmill spiroergometry was performed to determine the subjects’ maximum oxygen consumption. Subjects were excluded if they were too physically fit (maximum oxygen consumption >55 ml/kg/min) or had signs of cardiovascular abnormalities during the ergometry. The subjects were told that the aim of study was to characterize the behavioral effects of exercise on CCK-4-induced symptoms.
All subjects were studied twice on different days separated by 1 week. From 9:30 a.m. to 12:00 noon, the subjects were studied in a supine position in a soundproof room with a single bed. On the first day, the subjects were randomly assigned to one of two conditions: quiet rest or exercise (treadmill walking for 30 minutes at 70% of maximum oxygen consumption from 10:20 to 10:50 a.m.); the other condition was used on the second study day. Each subject received a bolus injection of 50 g of CCK-4 (Clinalfa, Laufelfingen, Switzerland) dissolved in 2 ml of 0.9% saline solution at 11:00 a.m. The Acute Panic Inventory (13) was administered at 10:00 a.m. (baseline), 10:55 a.m. (after rest or exercise), and 11:05 a.m. (after CCK-4 administration) by a rater blind to the procedure (A.S. or M.O.); the maximum intensity during the observation period was noted. To further characterize the possible effects of exercise, we used a previously described anxiety subscore (afraid of dying, general fear) (14, 15) and a somatic subscore (palpitations, breathing, and nausea) of the Acute Panic Inventory. A panic attack was noted when the Acute Panic Inventory total score exceeded 20 and an increment of at least 14 points over the -10:00 score was observed (13, 14, 16). The occurrence of a panic attack was confirmed by a trained psychiatrist. On the second study day, the subjects were additionally asked whether exercise reduced or increased CCK-4-induced symptoms or whether it had no influence at all.
The frequencies of panic attacks in the two treatment conditions were compared by using the McNemar paired chi-square test. The subjective experiences of whether exercise decreased, increased, or had no effect on CCK-4-induced symptoms were compared by using the chi-square test. For statistical comparison of mean Acute Panic Inventory scores and the subscores between the rest and the exercise conditions and among the three time points (10:00 a.m., 10:55 a.m., and 11:05 a.m.), a two-factor multivariate analysis of variance (MANOVA) with a repeated-measures design was performed. Treatment and time were the two within-subjects factors, with two or three levels. Hypothesis tests for the main and interaction effects of these factors were based on multivariate criteria, such as Wilks’s lambda and its approximated F value. When significant main or interaction effects were found, univariate F tests and/or tests with contrasts followed by MANOVA for investigating simple effects were performed. As a nominal level of significance, alpha=0.05 was accepted. To keep the type I error at ≤0.05, all post hoc tests (univariate F tests and tests with contrasts) were performed at a reduced level of significance (an adjusted alpha according to the Bonferroni procedure).

Results

The rates of panic attacks were significantly higher in the quiet rest than in the exercise conditions (12 of 15 versus six of 15) (p=0.03, McNemar’s test) (Table 1). Ten subjects estimated that exercise reduced CCK-4-induced symptoms, three did not experience a difference, and two subjects estimated that exercise increased CCK-4-induced symptoms (χ2=7.60, df=2, p=0.02).
MANOVAs of the Acute Panic Inventory score and the subscores revealed significant main effects of time (F=15.60, df=6, 52, p=0.001) and a significant interaction effect of time by exercise (F=3.11, df=6, 52, p=0.01). Univariate F tests indicated that the interaction of time by exercise was significant for the overall Acute Panic Inventory score (F=6.73, df=2, 28, p=0.01) and the anxiety subscale score (F=8.67, df=2, 28, p=0.007) and nearly significant for the somatic symptoms subscore (F=3.04, df=2, 28, p=0.09). When analyzing the simple effects of time on the Acute Panic Inventory score and the anxiety subscales, i.e., the differences of the last variables between the three time points, we found that CCK-4 increased the Acute Panic Inventory score and the anxiety subscore score compared to baseline (tests with contrasts in MANOVA, p<0.05). Compared to quiet rest, exercise significantly reduced the CCK-4-induced increase in the total Acute Panic Inventory score and the anxiety subscore (tests with contrasts in MANOVA, p<0.05).

Discussion

The main finding of this exploratory study was that 30 minutes of aerobic exercise had an acute antipanic activity. In healthy volunteers, the frequency of panic attacks and CCK-4-induced symptoms was significantly decreased after exercise. Subscore analysis of the Acute Panic Inventory scores indicated that exercise decreased CCK-4-induced anxiety symptoms rather than somatic symptoms. Additionally, the subjective experience of CCK-4-induced symptoms was decreased after exercise in most subjects.
Exercise has been shown to reduce somatic symptoms of anxiety induced by CO2 (9) and caffeine (10) in healthy volunteers. Our results for the first time suggest that exercise has an acute antipanic activity. Although it has already been demonstrated that exercise training for 10 weeks is anxiolytic in patients with panic disorder (4), our results suggest that acute exercise may have antipanic effects. If these effects are confirmed in patients with panic disorder, acute exercise may be used in the treatment of panic disorder as well. The optimum intensity and duration of acute exercise in achieving immediate antipanic effects will then have to be characterized in patients with panic disorder after prior exercise testing.
Numerous psychological and physiological mechanisms have been suggested to explain the beneficial effects of exercise on anxiety and depression (for a review, see reference 17). Experimental evidence suggests that the effects of exercise are on the synthesis and metabolism of monoamines. In addition, activation of β-endorphin secretion has been linked to the behavioral effects of exercise. The hypothalamic pituitary adrenocortical system (18) and its modulators—for example, atrial natriuretic peptide (16)—may be further involved in the antipanic effects of exercise.
In summary, our findings give evidence for an acute antipanic activity of exercise. If confirmed in patients, our results suggest that acute exercise may be used in the treatment of panic disorder as well. However, details about the optimum dosage (duration and intensity) remain to be characterized in patients.
TABLE 1

Footnote

Received Aug. 29, 2004; revision received Nov. 10, 2004; accepted Jan. 10, 2005. From the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, and the Section of Sports Medicine, Department of Internal Medicine III, Campus Benjamin Franklin, Charité-University Medicine Berlin. Address correspondence and reprint requests to Dr. Ströhle, Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-University Medicine Berlin, Schumannstr. 20/21, 10117 Berlin, Germany; [email protected] (e-mail). The authors thank Monika Hantschke-Brüggemann and Nancy Bock for technical assistance and Alexander Yassourids, Ph.D., for statistical advice.

References

1.
Long BC, Satvel RV: Effects of exercise training on anxiety: a meta analysis. J Appl Sport Psychol 1995; 7:167–189
2.
Dractu L: Physical exercise: an adjunctive treatment for panic disorder? Eur Psychiatry 2001; 16:372–374
3.
Sexton H, Mære Å, Dahl NH: Exercise intensity and reduction in neurotic symptoms. Acta Psychiatr Scand 1989; 80:231–235
4.
Broocks A, Bandelow B, Pekrun G, George A, Meyer T, Bartmann U, Hillmer-Vogel U, Rüther E: Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder. Am J Psychiatry 1998; 155:603–609
5.
Orwin A: Treatment of situational phobia—a case for running. Br J Psychiatry 1974; 125:95–98
6.
Muller B, Armstrong HE: A further note on the running treatment for anxiety. Psychother Theory Res Pract 1975; 12:385–387
7.
Barlow DH, Craske MG: Mastery of Your Anxiety and Panic. Albany, NY, Graywind Publications, 1994
8.
Cameron OG, Hudson CJ: Influence of exercise on anxiety levels in patients with anxiety disorders. Psychosomatics 1986; 27:720–723
9.
Esquivel G, Schruers K, Kuipers H, Griez E: The effects of acute exercise and high lactate levels on 35% CO2 challenge in healthy volunteers. Acta Psychiatr Scand 2002; 106:394–397
10.
Younstedt SD, O’Connor PJ, Crabbe JB, Dishman RK: Acute exercise reduces caffeine-induced anxiogenesis. Med Sci Sports Exerc 1998; 30:740–745
11.
Bradwejn J, Koszycki D, Shriqui C: Enhanced sensitivity of cholecystokinin tetrapeptide in panic disorder: clinical and behavioral findings. Arch Gen Psychiatry 1991; 48:603–610
12.
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59(suppl 20):22–33
13.
Dillon DJ, Gorman JM, Liebowitz MR, Fyer AJ, Klein DF: Measurement of lactate-induced panic and anxiety. Psychiatry Res 1987; 20:97–105
14.
Goetz RR, Klein DF, Gorman JM: Symptoms essential to the experience of sodium lactate-induced panic. Neuropsychopharmacology 1996; 14:355–366
15.
Ströhle A, Kellner M, Holsboer F, Wiedemann K: Anxiolytic activity of atrial natriuretic peptide in patients with panic disorder. Am J Psychiatry 2001; 158:1514–1516
16.
Ströhle A, Romeo E, di Michele F, Pasini A, Hermann B, Gajewsky G, Holsboer F, Rupprecht R: Induced panic attacks shift GABAA receptor modulatory neuroactive steroid composition in patients with panic disorder. Arch Gen Psychiatry 2003; 60:161–168
17.
Paluska SA, Schwenk TL: Physical activity and mental health: current concepts. Sports Med 2000; 29:167–180
18.
Ströhle A, Holsboer F: Stress responsive neurohormones in depression and anxiety. Pharmacopsychiatry 2003; 36(suppl 3):207–214

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 2376 - 2378
PubMed: 16330604

History

Published online: 1 December 2005
Published in print: December 2005

Authors

Details

Andreas Ströhle, M.D.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share